C. Martins
Molecular Biology · with Evan · 2006–2008
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 7 citations into it
- Oncology — 6 citations into it; #1,003 of 1,698 by trust here, #923 by citations
Whom C. Martins trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts C. Martins overall
Papers from C. Martins's perspective
Ordered by how strongly the researchers C. Martins trusts endorse each paper. Same corpus, a different order for every researcher.
- Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. (Cancer Research)
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis (Nature)
- Live or let die: the cell's response to p53 (Nature Reviews. Cancer)
- Surfing the p53 network (Nature)
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions (Nature)
- The role of p53 in determining sensitivity to radiotherapy (Nature Reviews. Cancer)
- c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. (Molecules and Cells)
- Intrinsic tumour suppression (Nature)
- A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus (Proceedings of the National Academy of Sciences of the United States of America)
- Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps (Cell Death and Differentiation)
Their papers
- Modelling Myc inhibition as a cancer therapy (2008) — 845 citations
- Modeling the therapeutic efficacy of p53 restoration in tumors. (2006) — 658 citations